The right tool for the right target: Letting biology drive modality selection

•  The biologics modalities available today are more innovative and diverse than ever, while at the same time many of our disease targets are increasingly complex  
• Matching the target with the most appropriate modality is a key strategy in leveraging our opportunities to bring life-changing treatments to patients   
• Through a diverse toolbox we can maximize the innovation available today for biologics drug discovery and development     

Rebecca Sendak, Head, Global Large Molecules Research Platform, Sanofi